Rehabilitation Research News: July 25, 2022

From the Director's Desk

Because of the Fourth of July holiday, I missed the last issue, so this newsletter is jam-packed. Here are the top things to know:

The Training in Grantsmanship in Rehabilitation Research (TIGRR) program is now accepting applications through August 5! If you are working on your first grant submission to NIH, now is the time to apply.
Mark your calendars! The National Institute of Neurological Disorders and Stroke (NINDS) and NICHD are hosting a virtual workshop August 17 and 18 to review the progress on the 2017 NINDS/NICHD Strategic Plan for Cerebral Palsy Research. Registration information is coming soon. This is a free meeting, and we hope you will attend.
NCMRR is seeking feedback from the community on our Research Infrastructure Program. We value your input on the future infrastructure needs of the rehabilitation research community. Please respond to Request for Information: Medical Rehabilitation Research Infrastructure Support (NOT-HD-22-029).

News

Elements of Style in Reproducible Workflow Creation and Analysis: A Kids First Training Event

August 22 to 26, 2022
11 a.m. to 1 p.m. ET each day

The Gabriella Miller Kids First Pediatric Research Program (Kids First) is an NIH Common Fund program focusing on the biology of childhood cancer and structural birth defects. The program created the Gabriella Miller Kids First Data Resource . This cloud-based platform publicly shares genetic and clinical data from childhood cancer and structural birth defect cohorts. It includes the Gabriella Miller Kids First Data Resource Portal and other tools to foster analysis and collaboration.

Join NIH Data and Technology Advancement (DATA) Scholar Anne Deslattes Mays, Ph.D., August 22 to 26 for 2 hours each day as she hosts this weeklong Kids First Data Resource training event and learn how to use and share reproducible analysis workflows in analyzing genomics and other “-omics” datasets in the cloud.

Over the course of five scheduled 2-hour sessions, users will learn:
- Reasoning with Jupyter Lab Notebooks (Python or R kernels)
- Code versioning with Git and GitHub
- Containerization with Conda and Docker
- Workflow development and execution

This class will use Seven Bridges' CAVATICA platform to conduct cloud-based analyses.

* Requirements include a web browser (Chrome preferred, registration through the Kids First Data Resource Center) and Internet access.

Space is limited for this event, so we suggest that you register early. Email info@kidsfirstdrc.org if you have any questions.

Notices and Funding Opportunities

NICHD Notices and Funding Opportunities

Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
- (NOT-OD-22-179)
- Multiple Institutes

BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)
- (RFA-EB-22-001)
- Multiple Institutes
- Application Receipt Date(s): Multiple dates; see announcement.

Notice of Intent to Publish a Funding Opportunity Announcement for BRAIN Initiative: Engineering and optimization of molecular technologies for functional dissection of neural circuits (UM1 Clinical Trial Not Allowed)
- (NOT-MH-22-265)
- Multiple Institutes

Notice of Special Interest: Alzheimer’s-Focused Administrative Supplements for NIH Grants that are Not Focused on Alzheimer’s Disease
- (NOT-AG-22-025)
- Multiple Institutes

Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes
- (NOT-OD-22-167)
- Multiple Institutes

Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
- (RFA-AR-23-001)
- Multiple Institutes
- Application Receipt Date(s): September 30, 2022

NIH Notices and Funding Opportunities

Register Today for the NIH Data Management and Sharing (DMS) Policy Webinar Series
- (NOT-OD-22-184)
- Office of the Director, NIH

Notice Announcing NIH All of Us Research Program Engagement, Communications, and Enrollment Partners Other Transactions (OT) Research Opportunity Announcement (ROA)
- (NOT-PM-22-003)
- Office of the Director, NIH

Notice of Intent to Publish a Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- (NOT-CA-22-110)
- National Cancer Institute
- National Institute of Neurological Disorders and Stroke

Notice of Intent to Publish a Funding Opportunity Announcement for Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)
- (NOT-CA-22-111)
- National Cancer Institute
- National Institute of Neurological Disorders and Stroke

Notice of Intent to Publish a Funding Opportunity Announcement for HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required)
- (NOT-NR-22-015)
- Multiple Institutes

Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)
- (PAR-22-203)
- Multiple Institutes
- Application Receipt Date(s): Multiple dates; see announcement.

Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029
- (NOT-AR-22-023)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases

Request for Information: Improving our understanding of the role of diet and other factors in the Developmental Origins of Health and Disease (DOHaD)
- (NOT-OD-22-157)
- Office of Nutrition Research

Notice of Participation of NIMHD in NOT-OD-22-126, Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
- (NOT-MD-22-020)
- National Institute on Minority Health and Health Disparities

Notice to Discontinue NINDS Participation in “Stephen I. Katz Early Stage Investigator Research Project Grant” Funding Opportunity Announcements PAR-21-038 and PAR-21-039
- (NOT-NS-23-017)
- National Institute of Neurological Disorders and Stroke

Notice of Change in Required Registrations for PA-22-179 “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)”
- (NOT-OD-22-161)
- Office of the Director, NIH

Notice of Change in Required Registrations for PA-22-177 “PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)”
- (NOT-OD-22-162)
- Office of the Director, NIH

Notice of Change in Required Registrations for PA-22-176 “PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)”
- (NOT-OD-22-163)
- Office of the Director, NIH

Notice of Change in Required Registrations for PA-22-178 “PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)”
- (NOT-OD-22-164)
- Office of the Director, NIH

Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
- (RFA-AG-23-017)
- National Institute on Aging
- Application Receipt Date(s): October 19, 2022

Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
- (PAR-22-213)
- National Institute on Aging
- Application Receipt Date(s): September 25, 2025

NIDA, NIMH, and NINDS Research Opportunities for New and “At-Risk” Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)

This FOA solicits R01 grant applications from “new investigators” and “at-risk investigators” from diverse backgrounds, including those from groups underrepresented in the health-related sciences (e.g., see NOT-OD-20-031, Notice of NIH’s Interest in Diversity), in order to enhance the diversity of R01-funded investigators.

Only applications that fall within the scientific missions of the National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), or National Institute of Neurological Disorders and Stroke (NINDS) will be considered for funding.

Program Announcement
- PAR-22-181
Due Dates for New Applications
- September 8, 2022; January 6, 2023; May 5, 2023; September 6, 2023; January 9, 2024; May 6, 2024; September 6, 2024; January 8, 2025; May 5, 2025
Due Dates for Resubmission Applications
- October 6, 2022; February 7, 2023; June 6, 2023; October 6, 2023; February 6, 2024; June 6, 2024; October 8, 2024; February 6, 2025; June 6, 2025
Funds Available
- NINDS intends to commit up to $10 million per fiscal year, approximately 25 awards, dependent on award amounts.
- NIDA intends to commit up to $5 million per fiscal year, 12 to 15 awards, dependent on award amounts.
- NIMH intends to commit up to $5 million per fiscal year, 12 to 15 awards, dependent on award amounts.
Definitions
- New investigator: A new investigator (NI) has had no previous NIH support as a principal investigator (PI) on a substantial independent research award. This includes early stage investigators (ESIs).
- At-risk investigator: An at-risk investigator has had previous support as a PI on a substantial independent research award and will have no substantial research grant funding in the following fiscal year unless successful in securing a substantial research grant award in the current fiscal year.
- Substantial independent research award: A substantial independent research award is any NIH research grant award, excluding smaller grants that maintain the recipient’s ESI and new investigator (NI) status. See the list of awards that an investigator can receive while still maintaining ESI/NI status.
Required Component
- Institutional Eligibility Letter is required for all applicants. The Institutional Eligibility Letter certifies that the program director (PD)/PI satisfies the eligibility criteria listed in the FOA under Section III, “Eligible Individuals (Program Director/Principal Investigator).” It must also include a statement explaining how the participation of the identified PD(s)/PI(s) would further the goals of the new and at-risk investigators to promote the Research Workforce Diversity Program, consistent with the Notice of NIH’s Interest in Diversity (NOT-OD-20-031). The Institutional Eligibility Letter must be signed by an institutional official and uploaded under Other Attachments. Applications missing an Institutional Eligibility Letter will be deemed incomplete and withdrawn.